Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sami Antoun

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
The American Journal of Clinical Nutrition|August 23, 2013
Central tenet of cancer cachexia therapy: do patients with advanced cancer have exploitable anabolic potential?Carla M Prado, Michael B Sawyer, Sunita Ghosh, et al.
Annals of Surgical Oncology|June 29, 2016
Sarcopenia is Associated with Chemotherapy Toxicity in Patients Undergoing Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Carcinomatosis from Colorectal CancerStéphanie Chemama, Mohamed Amine Bayar, Emilie Lanoy, et al.
European Journal of Cancer (Oxford, England : 1990)|August 18, 2015
High subcutaneous adipose tissue predicts the prognosis in metastatic castration-resistant prostate cancer patients in post chemotherapy settingSami Antoun, Amine Bayar, Ekatarina Ileana, et al.
The Journal of Clinical Endocrinology and Metabolism|April 2, 2013
Body composition variation and impact of low skeletal muscle mass in patients with advanced medullary thyroid carcinoma treated with vandetanib: results from a placebo-controlled studyMarie-Hélène Massicotte, Isabelle Borget, Sophie Broutin, et al.
Journal of Cachexia, Sarcopenia and Muscle|April 2, 2019
Staging of nutrition disorders in non-small-cell lung cancer patients: utility of skeletal muscle mass assessmentSami Antoun, Hugues Morel, Pierre-Jean Souquet, et al.
Cancer|June 27, 2013
Skeletal muscle density predicts prognosis in patients with metastatic renal cell carcinoma treated with targeted therapiesSami Antoun, Emilie Lanoy, Roberto Iacovelli, et al.
World Journal of Surgery|April 24, 2009
Nutritional risk factors in planned oncologic surgery: what clinical and biological parameters should be routinely used?Sami Antoun, Annie Rey, Jacqueline Béal, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 26, 2014
Diagnostic criteria for the classification of cancer-associated weight lossLisa Martin, Pierre Senesse, Ioannis Gioulbasanis, et al.
European Journal of Cancer (Oxford, England : 1990)|November 20, 2022
Protective effect of obesity on survival in cancers treated with immunotherapy vanishes when controlling for type of cancer, weight loss and reduced skeletal muscleSami Antoun, Emilie Lanoy, Samy Ammari, et al.
International Journal of Radiation Oncology, Biology, Physics|May 10, 2003
Fibrogenic signals in patients with radiation enteritis are associated with increased connective tissue growth factor expressionMarie Catherine Vozenin-Brotons, Fabien Milliat, Jean Christophe Sabourin, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
The American Journal of Clinical Nutrition|August 23, 2013
Central tenet of cancer cachexia therapy: do patients with advanced cancer have exploitable anabolic potential?Carla M Prado, Michael B Sawyer, Sunita Ghosh, et al.
Annals of Surgical Oncology|June 29, 2016
Sarcopenia is Associated with Chemotherapy Toxicity in Patients Undergoing Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Carcinomatosis from Colorectal CancerStéphanie Chemama, Mohamed Amine Bayar, Emilie Lanoy, et al.
European Journal of Cancer (Oxford, England : 1990)|August 18, 2015
High subcutaneous adipose tissue predicts the prognosis in metastatic castration-resistant prostate cancer patients in post chemotherapy settingSami Antoun, Amine Bayar, Ekatarina Ileana, et al.
The Journal of Clinical Endocrinology and Metabolism|April 2, 2013
Body composition variation and impact of low skeletal muscle mass in patients with advanced medullary thyroid carcinoma treated with vandetanib: results from a placebo-controlled studyMarie-Hélène Massicotte, Isabelle Borget, Sophie Broutin, et al.
Journal of Cachexia, Sarcopenia and Muscle|April 2, 2019
Staging of nutrition disorders in non-small-cell lung cancer patients: utility of skeletal muscle mass assessmentSami Antoun, Hugues Morel, Pierre-Jean Souquet, et al.
Cancer|June 27, 2013
Skeletal muscle density predicts prognosis in patients with metastatic renal cell carcinoma treated with targeted therapiesSami Antoun, Emilie Lanoy, Roberto Iacovelli, et al.
World Journal of Surgery|April 24, 2009
Nutritional risk factors in planned oncologic surgery: what clinical and biological parameters should be routinely used?Sami Antoun, Annie Rey, Jacqueline Béal, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 26, 2014
Diagnostic criteria for the classification of cancer-associated weight lossLisa Martin, Pierre Senesse, Ioannis Gioulbasanis, et al.
European Journal of Cancer (Oxford, England : 1990)|November 20, 2022
Protective effect of obesity on survival in cancers treated with immunotherapy vanishes when controlling for type of cancer, weight loss and reduced skeletal muscleSami Antoun, Emilie Lanoy, Samy Ammari, et al.
International Journal of Radiation Oncology, Biology, Physics|May 10, 2003
Fibrogenic signals in patients with radiation enteritis are associated with increased connective tissue growth factor expressionMarie Catherine Vozenin-Brotons, Fabien Milliat, Jean Christophe Sabourin, et al.
Pageof 4